Canadian, European and US regulators have announced their initial reactions to the discovery of N-nitrosodimethylamine, a probable human carcinogen, in ranitidine-based drugs.
Ranitidine – used to treat heartburn and stomach ulcers – is available in both prescription and OTC channels. It is...




